New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro (2016)
Source: BMC Biotechnology. Unidade: FMRP
Subjects: IMUNOTERAPIA, DIABETES MELLITUS, DOENÇAS AUTOIMUNES
ABNT
PILEGGI, Gecilmara Salviato et al. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro. BMC Biotechnology, v. 16, n. 1, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12896-016-0270-0. Acesso em: 13 nov. 2024.APA
Pileggi, G. S., Clemencio, A. D., Malardo, T., Antonini, S. R. R., Bonato, V. L. D., Rios, W. M., & Silva, C. L. (2016). New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro. BMC Biotechnology, 16( 1). doi:10.1186/s12896-016-0270-0NLM
Pileggi GS, Clemencio AD, Malardo T, Antonini SRR, Bonato VLD, Rios WM, Silva CL. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro [Internet]. BMC Biotechnology. 2016 ; 16( 1):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s12896-016-0270-0Vancouver
Pileggi GS, Clemencio AD, Malardo T, Antonini SRR, Bonato VLD, Rios WM, Silva CL. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro [Internet]. BMC Biotechnology. 2016 ; 16( 1):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s12896-016-0270-0